Polish Investing Ideas

zł330
104.3% overvalued intrinsic discount
Fair Value
Revenue
3.12% p.a.
Profit Margin
8%
Future PE
15x
Price in 2029
zł510.7
SNT logo
Synektik Spólka Akcyjna

Cardiac marker could be a hit

In 5 years, the company should still be thriving, entering new markets and expanding in existing ones. Positive passage of the third stage of testing of a new cardiac marker could help.Read more

View narrative
zł204.19
38.0% overvalued intrinsic discount
Fair Value
Revenue
8.49% p.a.
Profit Margin
13%
Future PE
22x
Price in 2029
zł311.79